CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-28 | WADE JEFFREY L President and CFO | Exercise or conversion | +30,467 | 224,147 | ||
| 2023-02-28 | WADE JEFFREY L President and CFO | Exercise or conversion | +11,176 | 235,323 | ||
| 2023-02-28 | WADE JEFFREY L President and CFO | Exercise or conversion | +37,273 | 272,596 | ||
| 2023-02-28 | WADE JEFFREY L President and CFO | Shares withheld for taxes | −30,255 | $2.17 | $66K | 242,341 |
| 2023-02-28 | WADE JEFFREY L President and CFO | Exercise or conversion · Restricted Stock Units | −30,467 | 0 | ||
| 2023-02-28 | WADE JEFFREY L President and CFO | Exercise or conversion · Restricted Stock Units | −11,176 | 11,177 | ||
| 2023-02-28 | WADE JEFFREY L President and CFO | Exercise or conversion · Restricted Stock Units | −37,273 | 74,547 | ||
| 2023-02-28 | COATS LONNEL Chief Executive Officer | Exercise or conversion | +84,630 | 670,633 | ||
| 2023-02-28 | COATS LONNEL Chief Executive Officer | Exercise or conversion | +33,334 | 703,967 | ||
| 2023-02-28 | COATS LONNEL Chief Executive Officer | Exercise or conversion | +91,363 | 795,330 | ||
| 2023-02-28 | COATS LONNEL Chief Executive Officer | Shares withheld for taxes | −50,971 | $2.17 | $111K | 744,359 |
| 2023-02-28 | COATS LONNEL Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −84,630 | 0 | ||
| 2023-02-28 | COATS LONNEL Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −33,334 | 33,333 | ||
| 2023-02-28 | COATS LONNEL Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −91,363 | 182,727 | ||
| 2023-02-09 | Alexander Kristen VP, Finance and Accounting | Grant or award · Restricted Stock Units | +47,780 | 47,780 | ||
| 2023-02-09 | Alexander Kristen VP, Finance and Accounting | Grant or award · Stock Option (Right to Buy) | +71,670 | 71,670 | ||
| 2023-02-09 | Seth Kiernan VP, Chief Commercial Officer | Grant or award · Restricted Stock Units | +93,370 | 93,370 | ||
| 2023-02-09 | Seth Kiernan VP, Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +280,100 | 280,100 | ||
| 2023-02-09 | McDermott Wendy VP, Human Resources | Grant or award · Restricted Stock Units | +83,090 | 83,090 | ||
| 2023-02-09 | McDermott Wendy VP, Human Resources | Grant or award · Stock Option (Right to Buy) | +249,280 | 249,280 |
Page 20 of 27 · 540 trades